Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;2(4):266-73.
doi: 10.3978/j.issn.2223-4292.2012.12.04.

Design considerations for targeted optical contrast agents

Affiliations

Design considerations for targeted optical contrast agents

Jeong Heon Lee et al. Quant Imaging Med Surg. 2012 Dec.

Abstract

Optical fluorescence imaging with the right combination of imaging modality and targeted contrast agents offers tremendous improvement in intraoperative imaging and clinical output (i.e., image-guided cancer surgery). Therefore, it is of paramount importance to gain an in-depth knowledge in the design of targeted contrast agents to meet clinical requirements. Currently, there are several clinically approved contrast agents available; however, none perform optimally in vivo by providing optimum sensitivity, stability, specificity, and safety for target imaging, diagnosis, and therapy. In this review, we discuss basic design considerations for targeted contrast agents in terms of optical and physicochemical properties, biological and physiological interactions, and biodistribution and targeting.

Keywords: Near-infrared imaging; biodistribution; optical imaging; targeted contrast agent.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative sizes of contrast agents: HD ranges for contrast agents useful for biomedical imaging (top row) and naturally occurring materials (bottom row). ICG = indocyanine green. The threshold between rapid renal clearance and hepatobiliary clearance is about 5.5 nm in HD. EPR (enhanced permeation and retention) is efficient when the size of an injected molecule is between 10 nm and 200 nm in HD. [Modified from Ref (12); Copyright permission from Decker Publishing]
Figure 2
Figure 2
Pharmacokinetics: the plasma half-life is composed of distribution phase (t1/2,α) and elimination phase (t1/2,β) as indicated in purple and blue colors, respectively. Shown are blood half-life examples obtained from ZW800-1 (28) (a small molecule, 1 nm in HD), QD-Cys (25) (a small nanoparticle, 5 nm in HD), and QD-PEG (26) (a typical-sized nanoparticle, 8 nm in HD)
Figure 3
Figure 3
In vivo NIR fluorescence imaging of nanoparticles in Sprague-Dawley rats. 20 pmol/g of PEGylated InAs(ZnS) quantum dots were injected intravenously 4 h prior to imaging. Abbreviations used are: DHLA, dihydrolipoic acid; PEG, polyethylene glycol; Ki, kidneys; Bl, bladder; Li, liver; Pa, pancreas; Sp, spleen; and In, intestine. λExc=667±11 nm; λEm=720 nm long pass. NIR fluorescence images have identical exposure times and normalizations. Scale bars =500 µm. [Adapted from Ref (26); Copyright permission from ACS Publications]

References

    1. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003;7:626-34 - PubMed
    1. Frangioni JV. New technologies for human cancer imaging. J Clin Oncol 2008;26:4012-21 - PMC - PubMed
    1. Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 2010;9:237-55 - PMC - PubMed
    1. Jang B, Park S, Kang SH, et al. Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo. Quant Imaging Med Surg 2012;2:1-11 - PMC - PubMed
    1. Kaneko OF, Willmann JK. Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg 2012;2:87-97 - PMC - PubMed